Putnam BioRevolution ETF (SYNB)

Assets	$5.27M
Expense Ratio	0.70%
PE Ratio	26.89
Shares Out	175,000
Dividend (ttm)	$0.21
Dividend Yield	0.71%
Ex-Dividend Date	Dec 5, 2024
Payout Frequency	Annual
Payout Ratio	19.20%

Volume	50
Open	30.27
Previous Close	29.96
Day's Range	30.27 - 30.27
52-Week Low	24.57
52-Week High	33.23
Beta	0.94
Holdings	35
Inception Date	Sep 29, 2022

About SYNB

Fund Home Page

The Putnam BioRevolution ETF (SYNB) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund actively invests in companies of all sizes around the globe that enable biological innovation. SYNB was launched on Sep 29, 2022 and is issued by Putnam.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NYSEARCA
• Ticker Symbol: SYNB
• ETF Provider: Putnam

Top 10 Holdings

50.31% of assets

Name	Symbol	Weight
Thermo Fisher Scientific Inc.	TMO	8.02%
Corteva, Inc.	CTVA	6.11%
AbbVie Inc.	ABBV	5.55%
Novozymes A/S	NVZMY	4.96%
Ascendis Pharma A/S	ASND	4.70%
NVIDIA Corporation	NVDA	4.66%
AstraZeneca PLC	AZN	4.45%
Bio-Rad Laboratories, Inc.	BIO	4.33%
Cadence Design Systems, Inc.	CDNS	3.96%
Eli Lilly and Company	LLY	3.57%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 5, 2024	$0.2139	Dec 9, 2024
Dec 6, 2023	$0.0211	Dec 11, 2023

Performance

SYNB had a total return of -7.82% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.87%.